Privia Health Group’s (PRVA) “Overweight” Rating Reiterated at Stephens

Stephens reissued their overweight rating on shares of Privia Health Group (NASDAQ:PRVA) in a research note published on Thursday morning,Benzinga reports. Stephens currently has a $32.00 price objective on the stock.

Several other brokerages have also recently issued reports on PRVA. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Privia Health Group in a report on Monday, December 1st. Evercore ISI boosted their price target on shares of Privia Health Group from $28.00 to $30.00 and gave the stock an “outperform” rating in a research report on Friday, November 7th. Canaccord Genuity Group upped their price target on shares of Privia Health Group from $32.00 to $34.00 and gave the company a “buy” rating in a research note on Wednesday, November 12th. Piper Sandler dropped their price objective on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating for the company in a research note on Monday, August 11th. Finally, JMP Securities boosted their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a report on Friday, August 29th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $30.00.

Privia Health Group Stock Down 0.7%

PRVA opened at $23.84 on Thursday. The company has a market capitalization of $2.93 billion, a PE ratio of 183.40, a price-to-earnings-growth ratio of 3.97 and a beta of 0.83. The firm has a 50-day simple moving average of $24.47 and a two-hundred day simple moving average of $22.75. Privia Health Group has a 52 week low of $18.77 and a 52 week high of $26.51.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Tuesday, June 7th. The company reported $0.10 earnings per share (EPS) for the quarter. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%.The firm had revenue of $213.61 million for the quarter. As a group, sell-side analysts expect that Privia Health Group will post 0.14 earnings per share for the current year.

Institutional Investors Weigh In On Privia Health Group

Institutional investors and hedge funds have recently modified their holdings of the business. Advantage Alpha Capital Partners LP purchased a new stake in shares of Privia Health Group during the second quarter valued at $3,941,000. Strs Ohio purchased a new position in Privia Health Group in the 1st quarter worth about $849,000. State of Alaska Department of Revenue lifted its holdings in Privia Health Group by 9.1% during the 2nd quarter. State of Alaska Department of Revenue now owns 62,406 shares of the company’s stock valued at $1,435,000 after buying an additional 5,223 shares in the last quarter. Yousif Capital Management LLC lifted its holdings in Privia Health Group by 2.5% during the 2nd quarter. Yousif Capital Management LLC now owns 39,687 shares of the company’s stock valued at $913,000 after buying an additional 955 shares in the last quarter. Finally, Edgestream Partners L.P. purchased a new stake in Privia Health Group in the 2nd quarter valued at about $2,209,000. 94.48% of the stock is owned by institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.